carcinogenesis

Adeno-associated virus in the liver: natural history and consequences in tumour development
Tiziana La Bella, Sandrine Imbeaud, Camille Peneau, Iadh Mami, Shalini Datta, Quentin Bayard, Stefano Caruso, Theo Z Hirsch, Julien Calderaro, Guillaume Morcrette, Catherine Guettier, Valerie Paradis, Giuliana Amaddeo, Alexis Laurent, Laurent Possenti, Laurence Chiche, Paulette Bioulac-Sage, Jean-Frederic Blanc, Eric Letouze, Jean-Charles Nault, Jessica Zucman-Rossi

Gut Apr 2020, 69 (4) 737-747; DOI: 10.1136/gutjnl-2019-318281
Oncofetal HLF transactivates c-Jun to promote hepatocellular carcinoma development and sorafenib resistance
Dai-Min Xiang, Wen Sun, Tengfei Zhou, Cheng Zhang, Zhuo Cheng, Shi-Chao Li, Weiqi Jiang, Ruoyu Wang, Gongbo Fu, Xiuliang Cui, Guojun Hou, Guang-Zhi Jin, Hengyu Li, Caiying Hou, Hui Liu, Hongyang Wang, Jin Ding

Gut Oct 2019, 68 (10) 1858-1871; DOI: 10.1136/gutjnl-2018-317440
DYRK1A modulates c-MET in pancreatic ductal adenocarcinoma to drive tumour growth
Jeroni Luna, Jacopo Boni, Miriam Cuatrecasas, Xavier Bofill-De Ros, Estela Núñez-Manchón, Meritxell Gironella, Eva C Vaquero, Maria L Arbones, Susana de la Luna, Cristina Fillat

Gut Aug 2019, 68 (8) 1465-1476; DOI: 10.1136/gutjnl-2018-316128
IPMNs with co-occurring invasive cancers: neighbours but not always relatives
Matthäus Felsenstein, Michaël Noë, David L Masica, Waki Hosoda, Peter Chianchiano, Catherine G Fischer, Gemma Lionheart, Lodewijk A A Brosens, Antonio Pea, Jun Yu, Georgios Gemenetzis, Vincent P Groot, Martin A Makary, Jin He, Matthew J Weiss, John L Cameron, Christopher L Wolfgang, Ralph H Hruban, Nicholas J Roberts, Rachel Karchin, Michael G Goggins, Laura D Wood

Gut Sep 2018, 67 (9) 1652-1662; DOI: 10.1136/gutjnl-2017-315062
Loss of KRAS control as consequence of downregulated microRNA-622 in hepatocellular carcinoma and its potential therapeutic implication
Heike Bantel, Ali Canbay

Gut Jul 2018, 67 (7) 1206-1207; DOI: 10.1136/gutjnl-2017-315630
The microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the Wnt/β-catenin signalling pathway
Jianxiang Chen, Muthukumar Rajasekaran, Hongping Xia, Xiaoqian Zhang, Shik Nie Kong, Karthik Sekar, Veerabrahma Pratap Seshachalam, Amudha Deivasigamani, Brian Kim Poh Goh, London Lucien Ooi, Wanjin Hong, Kam M Hui

Gut Sep 2016, 65 (9) 1522-1534; DOI: 10.1136/gutjnl-2015-310625
Interferon–microRNA signalling drives liver precancerous lesion formation and hepatocarcinogenesis
Yingcheng Yang, Ximeng Lin, Xinyuan Lu, Guijuan Luo, Tao Zeng, Jing Tang, Feng Jiang, Liang Li, Xiuliang Cui, Wentao Huang, Guojun Hou, Xin Chen, Qing Ouyang, Shanhua Tang, Huanlin Sun, Luonan Chen, Frank J Gonzalez, Mengchao Wu, Wenming Cong, Lei Chen, Hongyang Wang

Gut Jul 2016, 65 (7) 1186-1201; DOI: 10.1136/gutjnl-2015-310318
The acinar regulator Gata6 suppresses Kras^G12V-driven pancreatic tumorigenesis in mice
Paola Martinelli, Francesc Madriles, Marta Cañamero, Enrique Carrillo-de Santa Pau, Natalia del Pozo, Carmen Guerra, Francisco X Real

Gut Mar 2016, 65 (3) 476-486; DOI: 10.1136/gutjnl-2014-308042
The driving circuit of HBx and androgen receptor in HBV-related hepatocarcinogenesis
Sheng-Han Wang, Shiou-Hwei Yeh, Pei-Jer Chen

Gut Nov 2014, 63 (11) 1688-1689; DOI: 10.1136/gutjnl-2013-306678
Fibrolamellar hepatocellular carcinoma versus conventional hepatocellular carcinoma: better 5-year survival or artifactual result of research methodology?
Basile Njei

Gut Sep 2014, 63 (9) 1374-1375; DOI: 10.1136/gutjnl-2013-306333

Main menu

carcinogenesis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

carcinogenesis

Pages